Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Feb 7, 2025 (2 years ago)

Voriconazole Container Description: voriconazole The product…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Voriconazole Container Description: voriconazole The product packed in white poly bag containing black poly bag and tied each individual finally packed in HDPE container for shipping.

Drug: Voriconazole

Recalling firm
Aspen Biopharma Labs Pvt., Ltd.
Origin
India
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0265-2025 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Voriconazole recalls

See all
Class II · Moderate risk

Voriconazole Tablets

cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.

Terminated cGMP deviation Amerisource Health Services LLC NDC 60687-294-21 D-0307-2025
Class II · Moderate risk

Voriconazole 10mg/Ml

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Terminated Sterility / contamination Pharmacy Innovations D-0243-2023

Other recalls by Aspen Biopharma Labs Pvt., Ltd.

All 2025 recalls